Immunotherapy of childhood cancer


Session type:

John Anderson1
1Institute of Child Health, London, UK


The three speakers will provide an overview, illustrated by their own research, on the use of gene and cellular therapies to target paediatric leukaemia and neuroblastoma. Therapeutic approaches will cover bi-specific antibodies, chimeric antigen receptors and NK/NKT therapies. The importance of targeting the tumour stroma for effective therapies will be described in the context of new insights of tumour/stroma interactions in these conditions.